DentalReach Academic Editor:
With obstructive sleep apnea (OSA) becoming increasingly recognized for its systemic impact, a new development in pharmacotherapy may reshape how. A defensible application begins with diagnosis and baseline risk, then compares benefit, harm, alternatives, patient preference and maintenance burden.